Crossref journal-article
Public Library of Science (PLoS)
PLoS Genetics (340)
Bibliography

Cushman-Nick, M., Bonini, N. M., & Shorter, J. (2013). Hsp104 Suppresses Polyglutamine-Induced Degeneration Post Onset in a Drosophila MJD/SCA3 Model. PLoS Genetics, 9(9), e1003781.

Authors 3
  1. Mimi Cushman-Nick (first)
  2. Nancy M. Bonini (additional)
  3. James Shorter (additional)
References 97 Referenced 76
  1. 10.1038/nm1113 / Nat Med / Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs by MS Forman (2004)
  2. 10.1146/annurev.biochem.75.101304.123901 / Annu Rev Biochem / Protein misfolding, functional amyloid, and human disease by F Chiti (2006)
  3. 10.1242/jcs.051672 / J Cell Sci / Prion-like disorders: blurring the divide between transmissibility and infectivity by M Cushman (2010)
  4. 10.1080/13506120500032196 / Amyloid / Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis by P Westermark (2005)
  5. 10.1016/j.cell.2012.09.038 / Cell / Operational plasticity enables hsp104 to disaggregate diverse amyloid and nonamyloid clients by ME DeSantis (2012)
  6. 10.1111/j.1365-2958.2008.06135.x / Mol Microbiol / Substrate threading through the central pore of the Hsp104 chaperone as a common mechanism for protein disaggregation and prion propagation by P Tessarz (2008)
  7. 10.1016/j.cell.2007.10.047 / Cell / Atypical AAA+ subunit packing creates an expanded cavity for disaggregation by the protein-remodeling factor Hsp104 by P Wendler (2007)
  8. 10.1016/j.molcel.2009.02.026 / Mol Cell / Motor mechanism for protein threading through Hsp104 by P Wendler (2009)
  9. 10.1126/science.2188365 / Science / HSP104 required for induced thermotolerance by Y Sanchez (1990)
  10. 10.1038/372475a0 / Nature / Protein disaggregation mediated by heat-shock protein Hsp104 by DA Parsell (1994)
  11. 10.1016/j.cell.2009.02.044 / Cell / A systematic survey identifies prions and illuminates sequence features of prionogenic proteins by S Alberti (2009)
  12. 10.1126/science.1098007 / Science / Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers by J Shorter (2004)
  13. 10.1016/j.molcel.2006.05.042 / Mol Cell / Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities by J Shorter (2006)
  14. 10.1038/emboj.2012.264 / EMBO J / Metazoan Hsp70 machines use Hsp110 to power protein disaggregation by H Rampelt (2012)
  15. 10.1371/journal.pone.0026319 / PLoS One / The mammalian disaggregase machinery: Hsp110 synergizes with Hsp70 and Hsp40 to catalyze protein disaggregation and reactivation in a cell-free system by J Shorter (2011)
  16. 10.1371/journal.pbio.1001346 / PLoS Biol / Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans by ML Duennwald (2012)
  17. {'key': 'ref17', 'first-page': '1', 'article-title': 'Applying Hsp104 to protein-misfolding disorders', 'volume': '88', 'author': 'S Vashist', 'year': '2010', 'journal-title': 'Biochem Cell Biol'} / Biochem Cell Biol / Applying Hsp104 to protein-misfolding disorders by S Vashist (2010)
  18. 10.1159/000109760 / Neurosignals / Hsp104: a weapon to combat diverse neurodegenerative disorders by J Shorter (2008)
  19. 10.1186/1750-1172-6-35 / Orphanet J Rare Dis / Machado-Joseph Disease: from first descriptions to new perspectives by C Bettencourt (2011)
  20. 10.1016/B978-0-444-51892-7.00027-9 / Handb Clin Neurol / Machado-Joseph disease/spinocerebellar ataxia type 3 by H Paulson (2012)
  21. 10.1002/ana.410410408 / Ann Neurol / Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain by HL Paulson (1997)
  22. 10.1016/S0896-6273(00)80943-5 / Neuron / Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3 by HL Paulson (1997)
  23. 10.1038/ng0793-300 / Nat Genet / The gene for Machado-Joseph disease maps to human chromosome 14q by Y Takiyama (1993)
  24. 10.1074/jbc.M803692200 / J Biol Chem / The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains by BJ Winborn (2008)
  25. 10.1038/ncb2200 / Nat Cell Biol / The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis by K Kuhlbrodt (2011)
  26. 10.1016/S0014-5793(03)00748-8 / FEBS Lett / Domain architecture of the polyglutamine protein ataxin-3: a globular domain followed by a flexible tail by L Masino (2003)
  27. 10.1016/j.jmb.2007.02.058 / J Mol Biol / Mechanisms of ataxin-3 misfolding and fibril formation: kinetic analysis of a disease-associated polyglutamine protein by AM Ellisdon (2007)
  28. 10.1074/jbc.M601470200 / J Biol Chem / The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step by AM Ellisdon (2006)
  29. 10.1016/j.jmb.2004.09.065 / J Mol Biol / Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3 by L Masino (2004)
  30. 10.1038/emboj.2008.194 / EMBO J / Hsp104, Hsp70 and Hsp40 interplay regulates formation, growth and elimination of Sup35 prions by J Shorter (2008)
  31. 10.1172/JCI35781 / J Clin Invest / Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease by C Lo Bianco (2008)
  32. 10.1038/mt.sj.6300141 / Mol Ther / Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease by V Perrin (2007)
  33. 10.1073/pnas.100107297 / Proc Natl Acad Sci U S A / Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans by SH Satyal (2000)
  34. 10.1093/hmg/ddi372 / Hum Mol Genet / Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease by C Vacher (2005)
  35. 10.1016/j.neulet.2006.05.066 / Neurosci Lett / Infection by ME7 prion is not modified in transgenic mice expressing the yeast chaperone Hsp104 in neurons by F Dandoy-Dron (2006)
  36. 10.1021/bi0493766 / Biochemistry / Saccharomyces cerevisiae Hsp104 enhances the chaperone capacity of human cells and inhibits heat stress-induced proapoptotic signaling by DD Mosser (2004)
  37. 10.1523/JNEUROSCI.4778-07.2008 / J Neurosci / Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease by K Trinh (2008)
  38. 10.1242/dev.118.2.401 / Development / Targeted gene expression as a means of altering cell fates and generating dominant phenotypes by AH Brand (1993)
  39. 10.1523/JNEUROSCI.5894-09.2010 / J Neurosci / TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97 by GP Ritson (2010)
  40. 10.1016/S0092-8674(00)81200-3 / Cell / Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila by JM Warrick (1998)
  41. 10.1016/j.molcel.2005.02.030 / Mol Cell / Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism by JM Warrick (2005)
  42. 10.1074/jbc.M611914200 / J Biol Chem / Calpain inhibition is sufficient to suppress aggregation of polyglutamine-expanded ataxin-3 by A Haacke (2007)
  43. 10.1093/hmg/ddp456 / Hum Mol Genet / Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3 by J Jung (2009)
  44. 10.1038/502 / Nat Genet / Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 by CJ Cummings (1998)
  45. 10.1038/70532 / Nat Genet / Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70 by JM Warrick (1999)
  46. 10.1093/hmg/9.19.2811 / Hum Mol Genet / Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila by HY Chan (2000)
  47. 10.1073/pnas.140202897 / Proc Natl Acad Sci U S A / Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils by PJ Muchowski (2000)
  48. {'key': 'ref48', 'first-page': 'e838', 'article-title': 'Screening for amyloid aggregation by Semi-Denaturing Detergent-Agarose Gel Electrophoresis', 'volume': '17', 'author': 'R Halfmann', 'year': '2008', 'journal-title': 'J Vis Exp'} / J Vis Exp / Screening for amyloid aggregation by Semi-Denaturing Detergent-Agarose Gel Electrophoresis by R Halfmann (2008)
  49. 10.1128/jb.175.20.6484-6491.1993 / J Bacteriol / Genetic evidence for a functional relationship between Hsp104 and Hsp70 by Y Sanchez (1993)
  50. 10.1007/s10048-009-0216-y / Neurogenetics / Increased transcript diversity: novel splicing variants of Machado-Joseph disease gene (ATXN3) by C Bettencourt (2010)
  51. 10.1371/journal.pone.0013695 / PLoS One / Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties by GM Harris (2010)
  52. 10.1038/nsmb.2031 / Nat Struct Mol Biol / Dominant prion mutants induce curing through pathways that promote chaperone-mediated disaggregation by S DiSalvo (2011)
  53. 10.1002/gene.10133 / Genesis / Conditional expression of UAS-transgenes in the adult eye with a new gene-switch vector system by G Roman (2002)
  54. 10.1073/pnas.221303298 / Proc Natl Acad Sci U S A / A conditional tissue-specific transgene expression system using inducible GAL4 by T Osterwalder (2001)
  55. 10.1371/journal.pbio.1001052 / PLoS Biol / A yeast model of FUS/TLS-dependent cytotoxicity by S Ju (2011)
  56. 10.1038/ng.2434 / Nat Genet / Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models by M Armakola (2012)
  57. 10.1371/journal.pbio.1000614 / PLoS Biol / Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS by Z Sun (2011)
  58. 10.1038/nrg1616 / Nat Rev Genet / Prions as adaptive conduits of memory and inheritance by J Shorter (2005)
  59. 10.1016/j.chembiol.2012.09.013 / Chem Biol / Hsp104 drives “protein-only” positive selection of Sup35 prion strains encoding strong [PSI(+)] by ME DeSantis (2012)
  60. 10.1073/pnas.0812083106 / Proc Natl Acad Sci U S A / Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity by Y Nekooki-Machida (2009)
  61. 10.1016/j.cell.2010.11.050 / Cell / Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions by H Olzscha (2011)
  62. 10.4161/cc.10.10.15432 / Cell Cycle / Aberrant protein interactions in amyloid disease by RM Vabulas (2011)
  63. 10.1073/pnas.0802593105 / Proc Natl Acad Sci U S A / Chaperone-dependent amyloid assembly protects cells from prion toxicity by PM Douglas (2008)
  64. 10.1016/j.semcdb.2011.03.011 / Semin Cell Dev Biol / Amyloid in neurodegenerative diseases: friend or foe? by KJ Wolfe (2011)
  65. 10.1038/nature02261 / Nature / Protein folding and misfolding by CM Dobson (2003)
  66. 10.1073/pnas.170280697 / Proc Natl Acad Sci U S A / Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease by J Carmichael (2000)
  67. 10.1074/jbc.273.15.9158 / J Biol Chem / Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract by CL Wellington (1998)
  68. 10.1016/j.cell.2006.04.026 / Cell / Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin by RK Graham (2006)
  69. 10.1073/pnas.0604547103 / Proc Natl Acad Sci U S A / Flanking sequences profoundly alter polyglutamine toxicity in yeast by ML Duennwald (2006)
  70. 10.1016/j.bpj.2011.02.056 / Biophys J / The Josephin domain determines the morphological and mechanical properties of ataxin-3 fibrils by L Masino (2011)
  71. 10.1073/pnas.0501732102 / Proc Natl Acad Sci U S A / The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition by G Nicastro (2005)
  72. 10.1038/nrn1587 / Nat Rev Neurosci / Modulation of neurodegeneration by molecular chaperones by PJ Muchowski (2005)
  73. 10.1016/j.febslet.2009.04.029 / FEBS Lett / The role of molecular chaperones in human misfolding diseases by SA Broadley (2009)
  74. 10.1074/jbc.M505524200 / J Biol Chem / Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice by HY Shen (2005)
  75. 10.1016/j.bbrc.2004.07.021 / Biochem Biophys Res Commun / Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro by PJ McLean (2004)
  76. 10.1038/nm1102-1185 / Nat Med / Pharmacological prevention of Parkinson disease in Drosophila by PK Auluck (2002)
  77. 10.1038/nchembio.1140 / Nat Chem Biol / Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation by AM Wang (2012)
  78. 10.1016/S0197-4580(02)00065-9 / Neurobiol Aging / Staging of brain pathology related to sporadic Parkinson's disease by H Braak (2003)
  79. 10.1001/jama.283.12.1571 / JAMA / Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline by J Naslund (2000)
  80. 10.1016/S0092-8674(00)80513-9 / Cell / Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation by SW Davies (1997)
  81. 10.1056/NEJMoa0802268 / N Engl J Med / Effect of gene therapy on visual function in Leber's congenital amaurosis by JW Bainbridge (2008)
  82. 10.1056/NEJMoa012616 / N Engl J Med / Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy by S Hacein-Bey-Abina (2002)
  83. 10.1056/NEJMoa0802315 / N Engl J Med / Safety and efficacy of gene transfer for Leber's congenital amaurosis by AM Maguire (2008)
  84. 10.1073/pnas.0706006104 / Proc Natl Acad Sci U S A / Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease by A Feigin (2007)
  85. 10.1016/S0140-6736(07)60982-9 / Lancet / Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial by MG Kaplitt (2007)
  86. 10.1016/S0140-6736(07)60957-X / Lancet / Gene therapy for Parkinson's disease: early data by AJ Stoessl (2007)
  87. 10.1038/nrneurol.2013.103 / Nat Rev Neurol / Progress in gene therapy for neurological disorders by M Simonato (2013)
  88. 10.1007/s13311-013-0191-8 / Neurotherapeutics / Gene Therapy for Misfolding Protein Diseases of the Central Nervous System by W San Sebastian (2013)
  89. 10.1038/359832a0 / Nature / Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin by G Schiavo (1992)
  90. 10.1021/bi201490t / Biochemistry / Retargeted clostridial neurotoxins as novel agents for treating chronic diseases by FL Yeh (2011)
  91. 10.1056/NEJM199907083410209 / N Engl J Med / One man's poison–clinical applications of botulinum toxin by M Hallett (1999)
  92. 10.1016/j.toxicon.2009.01.022 / Toxicon / Botulinum toxin for the management of adult patients with upper motor neuron syndrome by A Esquenazi (2009)
  93. 10.1002/mds.22452 / Mov Disord / Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review by AE Elia (2009)
  94. 10.1097/00019052-199908000-00012 / Curr Opin Neurol / Botulinum toxin in motor disorders by AR Bentivoglio (1999)
  95. 10.1002/jnr.21171 / J Neurosci Res / The Janus faces of botulinum neurotoxin: sensational medicine and deadly biological weapon by SL Osborne (2007)
  96. 10.1242/dev.120.8.2121 / Development / Expression of baculovirus P35 prevents cell death in Drosophila by BA Hay (1994)
  97. 10.18632/aging.100018 / Aging (Albany NY) / A screen of apoptosis and senescence regulatory genes for life span effects when over-expressed in Drosophila by J Shen (2009)
Dates
Type When
Created 11 years, 11 months ago (Sept. 5, 2013, 5:22 p.m.)
Deposited 3 years, 5 months ago (March 5, 2022, 11:36 a.m.)
Indexed 5 days, 11 hours ago (Aug. 27, 2025, 11:39 a.m.)
Issued 11 years, 11 months ago (Sept. 5, 2013)
Published 11 years, 11 months ago (Sept. 5, 2013)
Published Online 11 years, 11 months ago (Sept. 5, 2013)
Funders 0

None

@article{Cushman_Nick_2013, title={Hsp104 Suppresses Polyglutamine-Induced Degeneration Post Onset in a Drosophila MJD/SCA3 Model}, volume={9}, ISSN={1553-7404}, url={http://dx.doi.org/10.1371/journal.pgen.1003781}, DOI={10.1371/journal.pgen.1003781}, number={9}, journal={PLoS Genetics}, publisher={Public Library of Science (PLoS)}, author={Cushman-Nick, Mimi and Bonini, Nancy M. and Shorter, James}, editor={Lu, Bingwei}, year={2013}, month=sep, pages={e1003781} }